Pharma Stocks
-
Stocks to Watch for June 1: IndiGo, Glenmark Pharma, Lupin, NMDC, textile stocks and more
1 / 10 InterGlobe Aviation | IndiGo reported a net loss of ₹2,536.3 crore for the fourth quarter, compared with…
Read More » -
SMS Pharmaceuticals’ (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Investors were disappointed with SMS Pharmaceuticals Limited’s (NSE:SMSPHARMA) earnings, despite the strong profit numbers. Our analysis uncovered some concerning factors…
Read More » -
Should You Be Adding Bliss GVS Pharma (NSE:BLISSGVS) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a…
Read More » -
Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Strength And Long Term Gains
Amneal Pharmaceuticals (AMRX) is back in focus after recent trading that left the stock with a 1 day gain of…
Read More » -
Bristol Myers Squibb’s Mezigdomide Data Reframes Multiple Myeloma Pipeline Story
Bristol Myers Squibb (NYSE:BMY) reported landmark positive Phase 3 SUCCESSOR-2 results for mezigdomide in relapsed or refractory multiple myeloma. The…
Read More » -
TSX Specialty Pharma Stocks Tracking Therapy Market Growth
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…
Read More » -
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, MA, May 29, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE),…
Read More » -
Why Is Ionis Pharmaceuticals (IONS) Up 3.4% Since Last Earnings Report?
It has been about a month since the last earnings report for Ionis Pharmaceuticals (IONS). Shares have added about 3.4%…
Read More » -
Canadian Healthcare Stocks Expanding Through Specialty Pharma Growth
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…
Read More » -
Merck Stock After a 60% Rally From Its Lows: Is It Still Worth Buying at $120?
Key Takeaways: MRK stock has rallied around 60% over the past year, climbing from a 52-week low of $75 to…
Read More »